

1. 87-42-3
2. 6-chloro-9h-purine
3. 6-chloro-7h-purine
4. 1h-purine, 6-chloro-
5. 6-chloro-1h-purine
6. Purine, 6-chloro-
7. 6-chlorpurine
8. 6-cp
9. 6-chloropurin-9-yl
10. Sk 6048
11. 6-chloropurin
12. Nsc 744
13. X 47
14. 111055-92-6
15. Mfcd00075825
16. Nsc-744
17. Oh8700156w
18. Clp
19. 6-chloropurine, Crystalline
20. 133762-83-1
21. Einecs 201-745-6
22. Ai3-26401
23. Ccris 3908
24. 6-chloro-purine
25. Unii-oh8700156w
26. 3kqo
27. Es4
28. 6-chlor-7h-purin
29. 6-chloropurine, 99%
30. Schembl9081
31. 6-chloropurine, >=99%
32. 6-chloropurine [mi]
33. Chembl140037
34. Nsc744
35. Schembl21121896
36. Zkbqdfawxltyks-uhfffaoysa-
37. Dtxsid00861673
38. Us9138393, 6-chloropurine
39. Us9144538, 6-chloropurine
40. Chebi:177625
41. Bdbm181123
42. Act02229
43. Albb-006044
44. Bcp27820
45. Hy-y0247
46. Str05267
47. Zinc4807217
48. S4801
49. Stk501251
50. Wln: T56 Bm Dn Fn Hnj Ig
51. Akos000267571
52. Akos005259271
53. 6-chloropurine, >=95.0% (hplc)
54. Ab02899
55. Ac-3252
56. Ccg-266258
57. Cs-w008651
58. Ps-3424
59. 6-chloro-9h-purine;6-chloro-7h-purine
60. Bp-10522
61. Sy004779
62. Db-007147
63. Am20110246
64. Ft-0601457
65. En300-30395
66. 74c891
67. 075c825
68. Ag-670/31548001
69. J-514884
70. W-104024
71. Q27285654
72. F0001-2162
| Molecular Weight | 154.56 g/mol |
|---|---|
| Molecular Formula | C5H3ClN4 |
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 154.0046238 g/mol |
| Monoisotopic Mass | 154.0046238 g/mol |
| Topological Polar Surface Area | 54.5 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 131 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)